1. 165: PePS2: Pembrolizumab in Performance Status 2 non-small-cell lung cancer. (January 2017) Authors: Brock, K.; Billingham, C.; Llewellyn, L.; Smith, H.; McNab, G.; Middleton, G. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗